Laser resurfacing may shield aging skin from cancer

NCT ID NCT06428721

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests whether a laser treatment called fractionated laser resurfacing (FLR) can protect the forearms of older adults from precancerous spots (actinic keratoses) and non-melanoma skin cancer. Participants are 60 or older with fair skin and at least five precancerous spots on each forearm. One forearm receives the laser treatment, while the other serves as a comparison. The study also explores whether skin photographs can predict where future spots or cancers will appear.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Fractionated Laser Resurfacing (FLR) — a laser that creates tiny holes in the skin's surface to rejuvenate it.
What this could lead to
If it works, this could offer a way to prevent skin cancer in older adults without daily creams or frequent doctor visits.
What could go wrong
This is a small, early study with 80 people, so results may not apply to everyone. The laser procedure can cause temporary redness, swelling, or discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACTINIC KERATOSES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Wright State Physicians

    RECRUITING

    Fairborn, Ohio, 45324, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.